The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

These are the stocks posting the largest moves midday.

SentinelOne reported earnings after the bell Thursday and issued lackluster guidance for the current quarter and full-year.

Dell reported its fastest pace of revenue growth since returning to the public market in 2018, with AI server revenue soaring 757% over last year.

Bowman said reacting to the inflation surge, driven primarily by energy prices and tariffs, has proven ineffective.

Replimune was among the drugmakers that had criticized the FDA for what they called inconsistent guidance around trials and approvals.

Here are five key things investors need to know to start the trading day.

Ives' comments come as part of a wider prediction for the Nasdaq to top 30,000 points by 2027, reiterating his call from earlier interviews with CNBC.

Anthropic's Mythos model, which has advanced cyber abilities, has prompted a wave of concern from governments and businesses.

In a post on X, Elon Musk offered details about SpaceX's deal with Anthropic that weren't included in the company's IPO prospectus.

Nvidia is investing billions into companies developing photonics, which industry watchers say could bring big efficiency gains to the AI sector.

These are the stocks posting the largest moves premarket.

Trump's eVTOL pilot program is giving the air taxi industry its validation, but legal battles have put investor sentiment on hold.

Is there a "luce" at the end of the tunnel for Ferrari's first electric vehicle?

Photonics is considered to be a more efficient alternative to the current process of transferring data using electricity, which could be crucial to the AI boom.

Jeff Bezos' rocket maker suffered a setback on Thursday as its New Glenn rocket went up in flames.

Shares of LG Electronics surged after it unveiled automotive innovations using Google technology.

Shares of Samsung Electronics surged after the company began shipping HBM4E chip samples to its customers globally.

The dynamic is emblematic of how business is seeking to sow favor with the president in his second term, and has departed from the norms of big business philanthropy.

Tesla has registered 42 automated vehicles in its driverless Robotaxi service in Texas, putting it far behind Waymo in the state.

Applied Materials CEO Gary Dickerson said the semiconductor industry is experiencing its strongest period ever.

CNBC’s Jim Cramer pointed to three reasons investors may be missing some of the market’s biggest AI winners.

See which stocks are posting big moves after the bell.

Dell has gone from being a sleepy legacy tech company to a high-growth AI story, assembling servers packed with graphics processing units.

CEO Todd McKinnon said Okta is "playing a long game" on AI and is allocating more resources to agentic tools.

Anthropic is now the most valuable AI company in Silicon Valley after a new $65 billion funding round.

It marks the seventh state the commission has sued in a dispute over who has the right to regulate event contract platforms.

Bill Miller, American Gaming Association president and CEO, added that prediction market platforms in his view amount to "backdoor sports betting."

The top five models for the $1,000-plus payments were popular pickup trucks including the Ford F-150, Chevrolet Silverado 1500 and Ram 1500.

These are the stocks posting the largest moves premarket.

Ferrari CEO Benedetto Vigna on Thursday said the cost of the manufacturer's new Luce model was a fair price to pay for innovation.

CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.

Ferrari has endured a firestorm of criticism following the launch of its first fully electric vehicle.

Chinese electric car company Nio has launched two lower-priced brands in the last two years to broaden its customer base in a sluggish Chinese consumer market.

The complaint from the Southern District of New York comes just over a month after another insider trading case on Polymarket.

See which stocks are posting big moves after the bell.

The Trump administration is ramping up efforts to crack down on fraud in the federal Medicaid program.

Lamborghini CEO said the automaker's decision to kill its EV to focus on plug-in hybrid electric vehicles was "the right way to go" for his company.

Despite reports Iran could return the passageway to normal traffic flows within a month of a peace deal, Kalshi traders thought that was unlikely.

The drugmaker announced it will buy three privately held vaccine makers in deals worth almost $4 billion combined.

A $20 billion deal would be among the largest in JPMorgan's history and could invite regulatory scrutiny given its position as the largest U.S. bank by assets.

The new products allow customers to create AI assistants capable of carrying out investing strategies or spending instructions with minimal human involvement.

These are the stocks posting the largest moves premarket.

Mainland China-based chip giants such as Cambricon saw their shares tumble on Wednesday.

Medical supply company Gentell sources raw materials from around the world, and the crisis at the Strait of Hormuz is causing volatility for its business.

The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.

Dan Gilbert honors his son Nick by funding research into neurofibromatosis, the rare disease that took Nick’s life.

Eli Lilly claims in a civil lawsuit that it's the victim of a $200 million plus drug rebate fraud tied to Pentecostal church bishops and businesses.

The CDC earlier Monday said an American had tested positive for Ebola in Africa.

Trump said he is increasing the number of products on the platform by nearly seven times, adding more than 600 generic drugs to the site.

No cases tied to the Ebola outbreak have been confirmed in the U.S., and the overall risk to the American public and travelers remains low.

The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.

U.S. drugmaker Bristol Myers Squibb inked a partnership with a Chinese company that some say could mark the next wave of collaboration across continents.

The CDC said the risk to the general public from hantavirus remains low.

Biogen said signals sugget the treatment decreases levels of tau and slows cognitive decline, particularly at the lowest dose.

For some experts, the outbreak is raising broader concerns about how equipped the U.S. is to respond to future infectious disease threats.

Makary's tenure was marked by internal dysfunction at the FDA, leadership turmoil and mounting backlash from drugmakers and physicians on regulatory decisions.

Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity injection Wegovy.

CNBC’s Jim Cramer said today’s market may resemble 1999 in some ways, but investors are punishing stocks even more aggressively.

The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.